Dr. Siniša Dovat, a physician-scientist and pediatric oncologist at Penn State Children’s Hospital and Penn State Cancer Institute, discusses genetic mutations and their relationship to poor outcomes from B-cell Acute Lymphoblastic Leukemia (B-ALL) in Hispanic and Latino children. He also talks about a novel therapeutic drug combination that may be the answer to this disparity.

View more data on this study here.